Mark Danta

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours

Mark Danta, David J. Brown, Sanjay Bhagani et al. · AIDS · 2007 · 412 citations

Life Sciences, Infectious Diseases, Microbiology +17

Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men

T van de Laar, Oliver G. Pybus, Sylvia M. Bruisten et al. · Gastroenterology · 2009 · 314 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Impact of HIV on Host‐Virus Interactions during Early Hepatitis C Virus Infection

Mark Danta, Nasser Semmo, Paolo Fabris et al. · The Journal of Infectious Diseases · 2008 · 116 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17